Cite
HARVARD Citation
Joe, R. et al. (n.d.). The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. European journal of cancer. pp. S57-S58. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Joe, R. et al. (n.d.). The AXL inhibitor, TP-0903, reverses EMT and shows activity in non-small cell lung cancer preclinical models. European journal of cancer. pp. S57-S58. [Online].